DYRK1A and Dravet syndrome: While much attention has been focused on the implications of exacerbated IFN signaling in DS-related innate immune disorders, we posit that these data should be revisited in the context of potential synergies with DYRK1A-dependent mechanisms driving or potentiating adaptive immune alterations.